Adenovirus Keratoconjunctivitis and Ophtalmology

Adenoviral Keratoconjunctivitis Clinical Trial

— ADV-OPH  

Official title:

Complications of Adenovirus Keratoconjunctivitis in Ophthalmologists and Orthoptists: Epidemiology and Risk Factor, a Retrospective Questionnaire Analysis

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04417244
• Other study ID #: 2020 ADV-OPH
• Status: Recruiting
• Start date: October 21, 2019
• Est. completion date: October 2022

Study information

• Verified date: May 2020
• Source: University Hospital, Clermont-Ferrand
• Contact: Lise Laclautre
• Phone: 0473754963
• Email: pormo_interne_drci[@]chu-clermontferrand.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Adenovirus conjunctivitis is an epidemic disease registered as a common occupational disease for ophthalmologists and orthoptists. It can leave corneal sequelae even several years after infection.

The primary aim of the study is to investigate the prevalence of these sequelae in the at-risk population of ophthalmologists and orthoptist.

Secondary aim are to describe administrative procedures (occupational disease declaration and sick leave),infections characteristics; and risk factors.

Description:

Adenovirus conjunctivitis is an epidemic disease registered as a common occupational disease for ophthalmologists and orthoptists. It can leave corneal sequelae even several years after infection.

The investigation tream create a nationwide anonymous retrospective questionnaire using the secure internet application REDCap® to build and manage the questionnaire addressed to ophtalmologists (interns, graduates and retirees) and orthoptists.

Investigator collect several characteristics such as general characteristics (sex, age range, profession), administrative procedure declaration (occupational disease declaration, sick leave, cessation of surgery); infection characteristics (bilaterality, season, anteriority, sequels, current therapy, professional discomfort), risk factor (refractive surgery history, wearing of eyeglasses or contact lenses, smoking, or corticosteroid therapy).

The primary aim of the study is to investigate the prevalence of these sequelae in the at-risk population of ophthalmologists and orthoptist. Secondary aim are to describe administrative procedures (occupational disease declaration and sick leave), infections characteristics; and risk factors such as a refractive surgery history, the wearing of eyeglasses or contact lenses, smoking, or corticosteroid therapy.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1000
• Est. completion date: October 2022
• Est. primary completion date: October 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Ophtalmologist or orthoptist (interns, graduates and retirees)

• French

Exclusion Criteria:

• Foreign practitionner

Related Conditions & MeSH terms

• Adenoviral Keratoconjunctivitis
• Adenoviridae Infections
• Keratoconjunctivitis

Locations

Country	Name	City	State
France	University hospital, Clermont-Ferrand	Clermont-Ferrand

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Clermont-Ferrand

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	epidemiology characteristics	history of adenovirus keratoconjunctivitis; history of sequels	Day 1
Primary	general characteristics - Sex	general characteristics - Sex	Day 1
Primary	general characteristics - Age range	general characteristics - Age range	Day 1
Primary	general characteristics - Profession	general characteristics - Profession	Day 1
Secondary	administrative procedure declaration	occupational disease declaration, sick leave, cessation of surgery and duration	Day 1
Secondary	infection characteristics	bilaterality, season, anteriority, sequels, current therapy, professional discomfort	Day 1
Secondary	risk factor	refractive surgery history, wearing of eyeglasses or contact lenses, smoking, corticosteroid therapy	Day 1